Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in <scp>US</scp> adults with diabetes: 2005‐2018-Reference-Cited by-同舟云学术

Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018

Published:2022-11-02 Issue:2 Volume:25 Page:516-525
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Li Piaopiao¹,Zhang Ping²,Guan Dawei¹,Guo Jingchuan¹³^ORCID,Zhang Yongkang⁴,Pavkov Meda E.²,Bullard Kai McKeever²,Shao Hui¹³^ORCID

Affiliation:

1. Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville Florida USA

2. Division of Diabetes Translation Centers for Disease Control and Prevention Atlanta Georgia USA

3. Center for Drug Evaluation and Safety, Department of Pharmaceutical Evaluation and Policy University of Florida College of Pharmacy Gainesville Florida USA

4. Department of Population Health Sciences Weill Cornell Medical College New York New York USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14894

Reference37 articles.

1. Longitudinal Study of Racial and Ethnic Differences in Developing End-Stage Renal Disease among Aged Medicare Beneficiaries

2. Racial/Ethnic Differences in Glycemic Control in Older Adults with Type 2 Diabetes: United States 2003–2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional socioeconomic deprivation associated with the use of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in adults with type 2 diabetes in Germany;Diabetes, Obesity and Metabolism;2024-07-09

2. Association between low cognitive performance and diabetes‐related health indicators across racial and ethnic groups in adults with diabetes;Diabetes, Obesity and Metabolism;2024-06-20

3. The impact of a statewide insulin copay cap policy for insured patients with diabetes in Utah;Journal of Managed Care & Specialty Pharmacy;2024-02-03

4. Glucose‐lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types;Diabetes, Obesity and Metabolism;2023-08-07

5. Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020;Annals of Pharmacotherapy;2023-06-15